BioVie Inc. Financing Cash Flow
BioVie Inc. (BIVI) reported Financing Cash Flow of $10.46 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- BioVie Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- BioVie Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00.
- BioVie Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BioVie Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $10.46M.
- BioVie Inc. net cash provided by (used in) financing activities for fiscal 2026 was $10.46M, a 17.82% decline from fiscal 2025.
- BioVie Inc. net cash provided by (used in) financing activities for fiscal 2025 was $12.73M.
- BioVie Inc. net cash provided by (used in) financing activities for fiscal 2023 was $55.37M, a 67.18% increase from fiscal 2022.
- BioVie Inc. net cash provided by (used in) financing activities for fiscal 2022 was $33.12M, a 121.88% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $10.46M 10-K · filed 2026-08-13 | |
| 2026-03-31 | $0.00 derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $10.46M S-1/A · filed 2026-08-06 | $10.46M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | $10.46M 10-Q · filed 2026-02-06 | $10.46M derived: sum of 3 quarters · filed 2026-08-13 | $10.46M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $10.46M 10-Q · filed 2025-11-10 | $10.46M derived: sum of 2 quarters · filed 2026-08-13 | $10.46M derived: sum of 3 quarters · filed 2026-08-13 | $23.42M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $0.00 derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $12.97M derived: sum of 3 quarters · filed 2026-08-13 | $12.73M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $0.00 derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | $12.97M derived: sum of 2 quarters · filed 2026-08-06 | $12.73M S-1/A · filed 2026-08-06 | $10.23M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | $12.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | $12.73M 10-Q · filed 2026-02-06 | $10.23M derived: sum of 3 quarters · filed 2026-08-06 | $26.20M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-09-30 | -$240.94K 10-Q · filed 2025-11-10 | -$2.74M derived: sum of 2 quarters · filed 2026-08-06 | $13.23M derived: sum of 3 quarters · filed 2026-08-06 | $18.16M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-06-30 | -$2.50M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $13.48M derived: sum of 2 quarters · filed 2026-08-06 | $18.40M derived: sum of 3 quarters · filed 2026-08-06 | $17.80M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $15.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $20.90M derived: sum of 2 quarters · filed 2025-05-12 | $20.30M 10-Q · filed 2025-05-12 | $21.57M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $4.33M 10-Q · filed 2025-02-11 | $5.60M derived: sum of 3 quarters · filed 2025-02-11 | $15.36M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-09-30 | -$594.16K 10-Q · filed 2024-11-13 | $674.27K derived: sum of 2 quarters · filed 2024-11-13 | $10.44M derived: sum of 3 quarters · filed 2024-11-13 | $42.97M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $11.04M derived: sum of 2 quarters · filed 2024-09-30 | $43.56M derived: sum of 3 quarters · filed 2024-09-30 | $55.37M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $9.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $42.30M derived: sum of 2 quarters · filed 2024-05-14 | $54.10M 10-Q · filed 2024-05-14 | $54.10M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $32.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $44.34M 10-Q · filed 2024-02-13 | $44.34M derived: sum of 3 quarters · filed 2024-02-13 | $44.34M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $11.81M 10-Q · filed 2023-11-08 | $11.81M derived: sum of 2 quarters · filed 2023-11-08 | $33.12M 10-Q · filed 2022-05-11 | $26.42M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $0.00 derived: sum of 2 quarters · filed 2023-08-16 | $14.61M derived: sum of 3 quarters · filed 2023-08-16 | $33.12M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $14.61M derived: sum of 2 quarters · filed 2023-05-12 | $33.12M 10-Q · filed 2023-05-12 | $33.29M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $14.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $33.12M 10-Q · filed 2023-02-10 | $33.29M derived: sum of 3 quarters · filed 2023-02-10 | $33.81M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-09-30 | $18.51M 10-Q · filed 2022-11-04 | $18.68M derived: sum of 2 quarters · filed 2022-11-04 | $14.76M 10-Q · filed 2022-05-11 | $19.20M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | $168.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $685.30K derived: sum of 2 quarters · filed 2022-09-27 | $685.30K derived: sum of 3 quarters · filed 2022-09-27 | $14.93M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $516.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | $516.55K derived: sum of 2 quarters · filed 2022-02-08 | $14.76M 10-Q · filed 2021-05-10 | $15.15M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | $14.24M 10-Q · filed 2022-02-08 | $14.64M derived: sum of 3 quarters · filed 2022-02-08 | $15.04M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-09-30 | $14.24M 10-Q · filed 2021-11-10 | $14.64M derived: sum of 2 quarters · filed 2021-11-10 | $15.04M derived: sum of 3 quarters · filed 2021-11-10 | $15.07M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $393.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $795.50K derived: sum of 2 quarters · filed 2021-08-30 | $825.50K derived: sum of 3 quarters · filed 2021-08-30 | $1.33M 10-K · filed 2021-08-30 | |
| 2020-03-31 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | $432.00K derived: sum of 2 quarters · filed 2021-05-10 | $932.00K 10-Q · filed 2021-05-10 | $932.00K derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-29 | $530.00K 10-Q · filed 2021-01-29 | $530.00K derived: sum of 3 quarters · filed 2021-01-29 | $530.00K derived: sum of 4 quarters · filed 2021-01-29 | |
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-05 | $500.00K derived: sum of 2 quarters · filed 2020-11-05 | $500.00K derived: sum of 3 quarters · filed 2020-11-05 | $764.00K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $0.00 derived: sum of 2 quarters · filed 2020-08-07 | $264.00K derived: sum of 3 quarters · filed 2020-08-07 | $2.80M 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $264.00K derived: sum of 2 quarters · filed 2020-05-13 | $2.80M 10-Q · filed 2020-05-13 | $3.02M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $2.80M 10-Q · filed 2020-02-13 | $3.02M derived: sum of 3 quarters · filed 2020-02-13 | $3.10M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | $2.53M 10-Q · filed 2019-11-19 | $2.76M derived: sum of 2 quarters · filed 2019-11-19 | $2.83M derived: sum of 3 quarters · filed 2019-11-19 | $2.97M derived: sum of 4 quarters · filed 2019-11-19 | |
| 2018-06-30 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $302.00K derived: sum of 2 quarters · filed 2019-09-27 | $442.00K derived: sum of 3 quarters · filed 2019-09-27 | $662.00K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $215.00K derived: sum of 2 quarters · filed 2019-05-10 | $435.00K 10-Q · filed 2019-05-10 | $530.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | $360.00K 10-Q · filed 2019-02-12 | $360.00K 10-Q · filed 2018-02-14 | $455.00K derived: sum of 3 quarters · filed 2019-02-12 | $754.51K derived: sum of 4 quarters · filed 2019-02-12 |
| 2017-09-30 | $220.00K 10-Q · filed 2018-11-14 | $315.00K derived: sum of 2 quarters · filed 2018-11-14 | $614.51K derived: sum of 3 quarters · filed 2018-11-14 | $712.00K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $394.51K derived: sum of 2 quarters · filed 2018-10-05 | $492.00K derived: sum of 3 quarters · filed 2018-10-05 | $505.00K 10-K · filed 2018-10-05 | |
| 2017-03-31 | $299.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $397.00K derived: sum of 2 quarters · filed 2018-05-14 | $410.00K 10-Q · filed 2018-05-14 | ||
| 2016-12-31 | $97.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $110.49K 10-Q · filed 2018-02-14 | |||
| 2016-09-30 | $13.00K 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | -$5.00 10-K · filed 2017-08-24 | ||||
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 | ||||
| 2014-03-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-09 | $508.21K 10-Q · filed 2014-05-09 | ||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-01-29 | $508.21K 10-Q · filed 2014-01-29 | |||
| 2013-09-30 | $508.21K 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | $508.21K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |